Conatus Pharmaceuticals Company Profile (NASDAQ:CNAT)

About Conatus Pharmaceuticals

Conatus Pharmaceuticals logoConatus Pharmaceuticals Inc. is a biotechnology company. The Company focuses on the development and commercialization of medicines to treat liver disease. The Company operates through commercialization and development of pharmaceutical products segment. The Company is engaged in developing emricasan, which is an orally active pan-caspase protease inhibitor for the treatment of patients with chronic liver disease. Emricasan has the potential to interrupt the progression of liver disease and provide treatment options in multiple areas of liver disease. Emricasan is designed to slow or halt the progression of chronic liver disease caused by fibrosis and cirrhosis. Emricasan works by inhibiting caspases, which are a family of related enzymes that plays as modulators of critical cellular functions, including functions that result in apoptosis and inflammation.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: CNAT
  • CUSIP:
Key Metrics:
  • Previous Close: $2.11
  • 50 Day Moving Average: $1.91
  • 200 Day Moving Average: $2.23
  • 52-Week Range: $1.40 - $6.02
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -1.64
  • P/E Growth: -0.04
  • Market Cap: $46.57M
  • Outstanding Shares: 22,072,000
  • Beta: 0.82
Profitability:
  • Return on Equity: -77.44%
  • Return on Assets: -67.94%
Debt:
  • Debt-to-Equity Ratio: 0.04%
  • Current Ratio: 9.62%
  • Quick Ratio: 9.62%
Additional Links:
Companies Related to Conatus Pharmaceuticals:

Analyst Ratings

Consensus Ratings for Conatus Pharmaceuticals (NASDAQ:CNAT) (?)
Ratings Breakdown: 1 Hold Rating, 5 Buy Ratings
Consensus Rating:Buy (Score: 2.83)
Consensus Price Target: $9.67 (358.14% upside)

Analysts' Ratings History for Conatus Pharmaceuticals (NASDAQ:CNAT)
Show:
DateFirmActionRatingPrice TargetDetails
8/30/2016FBR & CoReiterated RatingOutperform$16.00View Rating Details
8/5/2016Brean CapitalSet Price TargetBuy$7.00View Rating Details
7/1/2016Roth CapitalInitiated CoverageBuy -> BuyView Rating Details
11/17/2015JMP SecuritiesLower Price TargetMarket Outperform$10.00 -> $6.00View Rating Details
11/5/2015Stifel NicolausLower Price TargetBuy$11.00 -> $9.00View Rating Details
9/24/2015Piper Jaffray Cos.Reiterated RatingHold$5.00View Rating Details
9/22/2015HC WainwrightInitiated CoverageBuy$15.00View Rating Details
3/6/2015MLV & Co.Set Price TargetBuy$16.00View Rating Details
(Data available from 9/24/2014 forward)

Earnings

Earnings History for Conatus Pharmaceuticals (NASDAQ:CNAT)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/2/2016        
8/3/2016Q216($0.38)($0.30)ViewN/AView Earnings Details
5/5/2016Q116($0.35)($0.35)ViewN/AView Earnings Details
3/9/2016Q4($0.37)($0.30)ViewListenView Earnings Details
11/4/2015Q315($0.38)($0.31)ViewN/AView Earnings Details
8/5/2015Q215($0.34)($0.31)ViewN/AView Earnings Details
5/7/2015Q115($0.38)($0.38)ViewListenView Earnings Details
3/11/2015Q414($0.49)($0.34)ViewListenView Earnings Details
11/12/2014Q3($0.44)($0.42)ViewN/AView Earnings Details
8/13/2014Q214($0.40)($0.34)ViewListenView Earnings Details
5/13/2014Q1($0.33)($0.34)ViewN/AView Earnings Details
3/27/2014($0.27)($0.33)ViewN/AView Earnings Details
11/14/2013Q3($0.20)($0.28)ViewListenView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Conatus Pharmaceuticals (NASDAQ:CNAT)
Current Year EPS Consensus Estimate: $-1.3 EPS
Next Year EPS Consensus Estimate: $-1.29 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20163($0.44)($0.33)($0.37)
Q2 20163($0.43)($0.35)($0.38)
Q3 20163($0.39)($0.32)($0.36)
Q4 20163($0.41)($0.26)($0.34)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Conatus Pharmaceuticals (NASDAQ:CNAT)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Conatus Pharmaceuticals (NASDAQ:CNAT)
Insider Ownership Percentage: 28.50%
Institutional Ownership Percentage: 22.80%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
4/8/2015Daniel L KisnerDirectorBuy4,000$5.75$23,000.00View SEC Filing  
7/30/2013David F HaleDirectorBuy2,588$11.00$28,468.00View SEC Filing  
7/30/2013Luke EvninMajor ShareholderBuy165,265$11.00$1,817,915.00View SEC Filing  
7/30/2013Steven J MentoCEOBuy13,800$11.00$151,800.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Conatus Pharmaceuticals (NASDAQ:CNAT)
DateHeadline
News IconWhat is the Street Saying About Conatus Pharmaceuticals Inc ... - Frisco Fastball (NASDAQ:CNAT)
friscofastball.com - September 23 at 3:42 PM
News IconKeen Investors Find News on Conatus Pharmaceuticals Inc. (NASDAQ:CNAT) - Duncan Research (NASDAQ:CNAT)
www.duncanindependent.com - September 23 at 3:42 PM
News IconVolatile Stocks Under Street Updates: UnitedHealth Group Incorporated (NYSE:UNH), Conatus Pharmaceuticals Inc ... - Street Wise Report (press release) (blog) (NASDAQ:CNAT)
streetwisereport.com - September 22 at 4:27 PM
News IconPenny Stock Investors Keen on Shares of Conatus Pharmaceuticals Inc. (NASDAQ:CNAT) - Duncan Research (NASDAQ:CNAT)
www.duncanindependent.com - September 22 at 4:27 PM
News IconTop Biotechnology Stock Picking: Tobira Therapeutics, Inc. (TBRA), Conatus Pharmaceuticals Inc. (CNAT) - The Independent Republic (NASDAQ:CNAT)
theindependentrepublic.com - September 22 at 4:27 PM
News IconBiotech Stocks Worth a Closer Look: Conatus Pharmaceuticals Inc. (NASDAQ:CNAT), Tokai Pharmaceuticals, Inc ... - The Voice Registrar (NASDAQ:CNAT)
voiceregistrar.com - September 22 at 4:27 PM
insidermonkey.com logoWhy Collegium Pharmaceuticals Inc (COLL), Galmed Pharmaceuticals Ltd (GLMD) and Three Other Stocks Are Registering Significant Gains Today (NASDAQ:CNAT)
www.insidermonkey.com - September 22 at 4:27 PM
fxpips.com logoActive Stocks Climbing Today – OBAS, FNCX, NAII, GLMD, WINT, MCRB, DTSI (NASDAQ:CNAT)
www.fxpips.com - September 22 at 9:55 AM
finance.yahoo.com logo5 Biotech Stocks to Watch as Interest in NASH Increases (NASDAQ:CNAT)
finance.yahoo.com - September 22 at 9:55 AM
benzinga.com logo18 Stocks Moving In Tuesday's Pre-Market Session - Benzinga (NASDAQ:CNAT)
www.benzinga.com - September 21 at 4:55 PM
News IconConatus Pharmaceuticals Inc. (NASDAQ:CNAT) emricasan, was discovered to be potentially useful in treating the Zika ... - Inside Trade (NASDAQ:CNAT)
insidetrade.co - September 21 at 4:55 PM
thecountrycaller.com logoSimilar Considerations For Galmed Pharmaceuticals Ltd, Conatus Pharmaceuticals Inc, Intercept Pharmaceuticals Inc ... - TCC (NASDAQ:CNAT)
www.thecountrycaller.com - September 21 at 4:55 PM
News IconPre-Open Stock Movers 09/20: (TBRA) (CNAT) (WINT) Higher; (ASNA) (MGT) (SEAS) Lower (more…) – StreetInsider.com (NASDAQ:CNAT)
news.xfoor.com - September 21 at 8:21 AM
News IconNasdaq Composite Index Looks Calm on Surface but One Stock Gained +720% Today (NASDAQ:CNAT)
www.economiccalendar.com - September 21 at 8:21 AM
wsj.com logoAllergan to Buy Tobira Therapeutics in $1.7 Billion Deal (NASDAQ:CNAT)
www.wsj.com - September 21 at 8:21 AM
streetinsider.com logoPre-Open Stock Movers 09/20: (TBRA) (CNAT) (WINT) Higher; (ASNA) (MGT) (SEAS) Lower (more...) (NASDAQ:CNAT)
www.streetinsider.com - September 21 at 8:21 AM
wsj.com logo[$$] Allergan to Buy Tobira Therapeutics in $1.7 Billion Deal (NASDAQ:CNAT)
www.wsj.com - September 21 at 8:21 AM
kcregister.com logoWhats Hot Today: Facebook Inc (NASDAQ:FB), Conatus Pharmaceuticals Inc. (NASDAQ:CNAT), Alphabet Inc ... - KC Register (NASDAQ:CNAT)
www.kcregister.com - September 17 at 9:03 AM
News IconStock Update on Earnings & Estimates for Conatus Pharmaceuticals Inc. (NASDAQ:CNAT) - Frisco Fastball (NASDAQ:CNAT)
friscofastball.com - September 16 at 5:30 AM
News IconAnalysts Place Conatus Pharmaceuticals Inc. (NASDAQ:CNAT) Under the Lens of the Microscope - Post News (NASDAQ:CNAT)
www.kentuckypostnews.com - September 15 at 4:41 PM
News IconAnalysts Place Conatus Pharmaceuticals Inc. (NASDAQ:CNAT) Under the Lens of the Microscope - Post News (NASDAQ:CNAT)
www.kentuckypostnews.com - September 15 at 4:41 PM
News IconSell-side is Weighing in on Conatus Pharmaceuticals Inc. (NASDAQ:CNAT) Earnings - Frisco Fastball (NASDAQ:CNAT)
friscofastball.com - September 15 at 4:41 PM
News IconSell-side is Weighing in on Conatus Pharmaceuticals Inc. (NASDAQ:CNAT) Earnings - Frisco Fastball (NASDAQ:CNAT)
friscofastball.com - September 15 at 4:41 PM
News IconWhat are Analysts Expecting for Conatus Pharmaceuticals Inc. (NASDAQ:CNAT) Earnings? - Frisco Fastball (NASDAQ:CNAT)
friscofastball.com - September 14 at 9:32 PM
News IconConatus Pharmaceuticals Inc. (NASDAQ:CNAT) topped earnings-per-share estimates 50% of the time - The Independent Republic (NASDAQ:CNAT)
theindependentrepublic.com - September 8 at 8:00 AM
News IconPlacing Conatus Pharmaceuticals Inc. (NASDAQ:CNAT) Shares Under the Microscope - Post News (NASDAQ:CNAT)
www.kentuckypostnews.com - September 8 at 8:00 AM
kcregister.com logoTraders Are Watching: Conatus Pharmaceuticals Inc. (NASDAQ ... - KC Register (NASDAQ:CNAT)
www.kcregister.com - September 7 at 4:20 PM
News IconStock Gapping Up Pre-Market: Conatus Pharmaceuticals Inc. (NASDAQ:CNAT) - Post News (NASDAQ:CNAT)
www.kentuckypostnews.com - September 1 at 4:12 PM
News IconConatus Pharmaceuticals Inc. (NASDAQ: CNAT) Outperform Rating Reiterated at FBR & Co - BNB Daily (blog) (NASDAQ:CNAT)
www.baseball-news-blog.com - September 1 at 4:12 PM
News IconConatus (CNAT) Surges on Liver Drug’s Potential Zika Effect (NASDAQ:CNAT)
www.economiccalendar.com - August 30 at 4:18 PM
insidermonkey.com logoWhy The Zika News Might Not Be So Great For Conatus Pharmaceuticals Inc (CNAT) (NASDAQ:CNAT)
www.insidermonkey.com - August 30 at 4:18 PM
wsj.com logo[$$] Potential Zika Virus Therapies Identified by Researchers (NASDAQ:CNAT)
www.wsj.com - August 29 at 9:33 PM
News IconShares Climbing Higher in Session: Conatus Pharmaceuticals Inc. (NASDAQ:CNAT) - Post News (NASDAQ:CNAT)
www.kentuckypostnews.com - August 29 at 4:30 PM
thestreet.com logoConatus Pharmaceuticals (CNAT) Stock Surges, Liver Drug Could Treat Zika (NASDAQ:CNAT)
www.thestreet.com - August 29 at 4:30 PM
prnewswire.com logoExalenz Bioscience Announces Collaboration with Conatus Pharmaceuticals to Use BreathID® to Monitor Patients with Cirrhosis Associated with NASH (NASDAQ:CNAT)
www.prnewswire.com - August 29 at 8:59 AM
News IconIs it Time to Buy Conatus Pharmaceuticals Inc. (NASDAQ:CNAT)? The Consensus Is In - Post News (NASDAQ:CNAT)
www.kentuckypostnews.com - August 25 at 9:15 AM
investornewswire.com logoConatus Pharmaceuticals Inc. (NASDAQ:CNAT) Gets 0 Recommendations To Sell - Investor Newswire (NASDAQ:CNAT)
www.investornewswire.com - August 23 at 4:25 PM
News IconStreet Consensus on Conatus Pharmaceuticals Inc. (NASDAQ:CNAT) - Post News (NASDAQ:CNAT)
www.kentuckypostnews.com - August 20 at 7:29 AM
investornewswire.com logoWill Conatus Pharmaceuticals Inc. (NASDAQ:CNAT) Hit $17 Price Target? - Investor Newswire (NASDAQ:CNAT)
www.investornewswire.com - August 17 at 4:27 PM
finance.yahoo.com logoCONATUS PHARMACEUTICALS INC. Financials (NASDAQ:CNAT)
finance.yahoo.com - August 13 at 4:16 PM
News IconStock Update on Conatus Pharmaceuticals Inc. (NASDAQ:CNAT) - Duncan Research (NASDAQ:CNAT)
www.duncanindependent.com - August 11 at 10:07 PM
biz.yahoo.com logoCONATUS PHARMACEUTICALS INC. Files SEC form 10-Q, Quarterly Report (NASDAQ:CNAT)
biz.yahoo.com - August 5 at 4:21 PM
twst.com logoConatus Pharmaceuticals Inc.: Conatus Pharmaceuticals Reports Second Quarter 2016 Financial Results and Program Updates (NASDAQ:CNAT)
www.twst.com - August 4 at 11:34 AM
zacks.com logoConatus (CNAT) Posts Narrower Q2 Loss, Emricasan in Focus (NASDAQ:CNAT)
www.zacks.com - August 4 at 11:34 AM
sg.finance.yahoo.com logoConatus reports 2Q loss (NASDAQ:CNAT)
sg.finance.yahoo.com - August 3 at 9:57 PM
finance.yahoo.com logoConatus Pharmaceuticals Reports Second Quarter 2016 Financial Results and Program Updates (NASDAQ:CNAT)
finance.yahoo.com - August 3 at 4:24 PM
biz.yahoo.com logoCONATUS PHARMACEUTICALS INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements (NASDAQ:CNAT)
biz.yahoo.com - August 3 at 4:23 PM
biz.yahoo.com logoQ2 2016 Conatus Pharmaceuticals Inc Earnings Release - After Market Close (NASDAQ:CNAT)
biz.yahoo.com - August 3 at 11:00 AM
finance.yahoo.com logoConatus (CNAT) May Surprise in Q2 Earnings: Stock to Gain? (NASDAQ:CNAT)
finance.yahoo.com - August 2 at 9:05 AM
globenewswire.com logoConatus Pharmaceuticals to Report Second Quarter 2016 Financial Results - GlobeNewswire (press release) (NASDAQ:CNAT)
globenewswire.com - July 27 at 12:53 PM

Social

Conatus Pharmaceuticals (NASDAQ:CNAT) Chart for Saturday, September, 24, 2016


Last Updated on 9/24/2016 by MarketBeat.com Staff